Preventing tuberculosis with community-based care in an HIV-endemic setting: a modeling analysis.

Differentiated care HIV epidemiology TB cost effectiveness gender modeling

Journal

medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986

Informations de publication

Date de publication:
22 Aug 2023
Historique:
pubmed: 4 9 2023
medline: 4 9 2023
entrez: 4 9 2023
Statut: epublish

Résumé

Antiretroviral therapy (ART) and TB preventive treatment (TPT) both prevent tuberculosis (TB) disease and deaths among people living with HIV. Differentiated care models, including community-based care, can increase uptake of ART and TPT to prevent TB in settings with a high burden of HIV-associated TB, particularly among men. We developed a gender-stratified dynamic model of TB and HIV transmission and disease progression among 100,000 adults ages 15-59 in KwaZulu-Natal, South Africa. We drew model parameters from a community-based ART initiation and resupply trial in sub-Saharan Africa (Delivery Optimization for Antiretroviral Therapy, DO ART) and other scientific literature. We simulated the impacts of community-based ART and TPT care programs during 2018-2027, assuming that community-based ART and TPT care were scaled up to similar levels as in the DO ART trial (i.e., ART coverage increasing from 49% to 82% among men and from 69% to 83% among women) and sustained for ten years. We projected the number of TB cases, deaths, and disability-adjusted life years (DALYs) averted relative to standard, clinic-based care. We calculated program costs and incremental cost-effectiveness ratios from the provider perspective. If community-based ART care could be implemented with similar effectiveness to the DO ART trial, increased ART coverage could reduce TB incidence by 27.0% (range 21.3% - 34.1%) and TB mortality by 36.0% (range 26.9% - 43.8%) after ten years. Increasing both ART and TPT uptake through community-based ART with TPT care could reduce TB incidence by 29.7% (range 23.9% - 36.0%) and TB mortality by 36.0% (range 26.9% - 43.8%). Community-based ART with TPT care reduced gender disparities in TB mortality rates by reducing TB mortality among men by a projected 39.8% (range 32.2% - 46.3%) and by 30.9% (range 25.3% - 36.5%) among women. Over ten years, the mean cost per DALY averted by community-based ART with TPT care was $846 USD (range $709 - $1,012). By substantially increasing coverage of ART and TPT, community-based care for people living with HIV could reduce TB incidence and mortality in settings with high burdens of HIV-associated TB and reduce TB gender disparities.

Identifiants

pubmed: 37662260
doi: 10.1101/2023.08.21.23294380
pmc: PMC10473784
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NIAID NIH HHS
ID : K01 AI138620
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR002317
Pays : United States

Déclaration de conflit d'intérêts

Competing interests The authors declare no competing interests.

Auteurs

Jennifer M Ross (JM)

Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, USA.

Chelsea Greene (C)

Department of Industrial and Systems Engineering, University of Washington, Seattle, USA.

Cara J Bayer (CJ)

Department of Epidemiology, University of North Carolina, Chapel Hill, USA.

David W Dowdy (DW)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.

Alastair van Heerden (A)

Centre for Community Based Research, Human Sciences Research Council, Pietermaritzburg, South Africa.
SAMRC/Wits Developmental Pathways for Health Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

Jesse Heitner (J)

Division of Infectious Diseases, Massachusetts General Hospital, Boston, USA.

Darcy W Rao (DW)

Bill & Melinda Gates Foundation, Seattle, USA.

D Allen Roberts (DA)

Department of Epidemiology, University of Washington, Seattle, USA.

Adrienne E Shapiro (AE)

Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, USA.
Department of Global Health, University of Washington, Seattle, USA.

Zelda B Zabinsky (ZB)

Department of Industrial and Systems Engineering, University of Washington, Seattle, USA.

Ruanne V Barnabas (RV)

Division of Infectious Diseases, Massachusetts General Hospital, Boston, USA.
Harvard Medical School, Boston, USA.

Classifications MeSH